Biosimilars And Follow-On Biologics: World Market 2013-2023 Sacramento Bee Our study forecasts revenues of prominent biosimilar agents at molecular level: • Rituximab • Infliximab • Trastuzumab. There you discover how high sales can go, to 2023, with individual forecasts. You see what's happening, understanding trends ... |
